An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome
A Panoskaltsis-Mortari, M Griese… - American journal of …, 2011 - atsjournals.org
Rationale: Acute lung dysfunction of noninfectious etiology, known as idiopathic pneumonia
syndrome (IPS), is a severe complication following hematopoietic stem cell transplantation …
syndrome (IPS), is a severe complication following hematopoietic stem cell transplantation …
Idiopathic pneumonia syndrome after bone marrow transplantation
JG Clark, JA Hansen, MI Hertz, R Parkman… - American Review of …, 1993 - atsjournals.org
Introduced in the early 1970sfor treatment of aplastic anemia and leukemia, bone marrow
transplantation offers potentially effective treatment for a growing number of patients. The …
transplantation offers potentially effective treatment for a growing number of patients. The …
[HTML][HTML] Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia …
GA Yanik, MM Horowitz, DJ Weisdorf, BR Logan… - Biology of Blood and …, 2014 - Elsevier
Idiopathic pneumonia syndrome (IPS) is a diffuse, noninfectious lung injury that occurs
acutely after allogeneic hematopoietic cell transplantation (HCT). IPS-related mortality has …
acutely after allogeneic hematopoietic cell transplantation (HCT). IPS-related mortality has …
Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies
Newer diagnostic methods may link more idiopathic pneumonia syndrome (IPS) cases to an
infectious agent. Bronchoalveolar lavage (BAL) samples from 69 hematopoietic cell …
infectious agent. Bronchoalveolar lavage (BAL) samples from 69 hematopoietic cell …
IDIOPATHIC PNEUMONIA SYNDROME: Changing Spectrum of Lung Injury after Marrow Transplantation: 1
SP Kantrow, RC Hackman, M Boeckh, D Myerson… - …, 1997 - journals.lww.com
Background. The aim of our study was to describe the incidence, clinical course, and risk
factors for the idiopathic pneumonia syndrome (IPS), compared with those previously …
factors for the idiopathic pneumonia syndrome (IPS), compared with those previously …
Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell …
T Fukuda, RC Hackman, KA Guthrie, BM Sandmaier… - Blood, 2003 - ashpublications.org
Idiopathic pneumonia syndrome (IPS) is a significant noninfectious complication of
hematopoietic stem cell transplantation (HSCT). We compared the incidences and outcomes …
hematopoietic stem cell transplantation (HSCT). We compared the incidences and outcomes …
Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre‐transplant radiation conditioning and local cytokine dysregulation in promoting lung …
G Shankar, DA Cohen - International journal of experimental …, 2001 - Wiley Online Library
Pulmonary complications and graft‐vs.‐host disease (GVHD) remain severe threats to
survival after bone marrow transplantation (BMT). Idiopathic pneumonia syndrome (IPS) …
survival after bone marrow transplantation (BMT). Idiopathic pneumonia syndrome (IPS) …
Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?
KR Cooke, G Yanik - Bone marrow transplantation, 2004 - nature.com
Allogeneic hematopoietic stem cell transplantation (SCT) is an important therapeutic option
for a number of malignant and nonmalignant conditions but the broader application of this …
for a number of malignant and nonmalignant conditions but the broader application of this …
Donor-derived TNF-α regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow …
GC Hildebrandt, KM Olkiewicz, LA Corrion, Y Chang… - Blood, 2004 - ashpublications.org
Idiopathic pneumonia syndrome (IPS) is a significant cause of mortality after allogeneic
bone marrow transplantation (allo-BMT), and tumor necrosis factor-α (TNF-α) is a significant …
bone marrow transplantation (allo-BMT), and tumor necrosis factor-α (TNF-α) is a significant …
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell …
Idiopathic pneumonia syndrome (IPS) refers to a diffuse, noninfectious, acute lung injury
after hematopoietic stem cell transplantation. Historically, IPS is associated with respiratory …
after hematopoietic stem cell transplantation. Historically, IPS is associated with respiratory …